Hip replacement patients may use fewer opioids with a simple change

NCT ID NCT07672808

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether giving patients a printed opioid prescription instead of sending it directly to the pharmacy can reduce opioid use after total hip replacement. About 100 adults will be randomly assigned to receive either the standard pain regimen with automatic pharmacy delivery or the same medications but with a printed opioid prescription they must choose to fill. Participants track pain, nausea, and medication use for three weeks, and researchers follow their recovery for three months. The goal is to see if this simple change cuts opioid use without sacrificing pain control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

multimodal pain regimen (standard vs. opioid-reduced with printed prescription)

What this could lead to

If it works, this approach could help patients use fewer opioids after hip replacement while still managing pain well, potentially lowering addiction risks.

What could go wrong

This is a small, early-stage study (100 people) at one hospital, so results may not apply broadly. Some patients might have more pain or nausea without the automatic opioid prescription.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHROPLASTY, REPLACEMENT, HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Henry Ford Hospital

    Detroit, Michigan, 48202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••